more than 5 L can be reproducibly spotted at each application. Repeated spotting is time-consuming and very subject to operator error.
We have found that only 5 to 10 L of solvent need be added to the extract, if this is sited in a round-bottomed tube. The solvent is then brought into contact with all the extract by using a relatively thick, round-bottomed glass rod, which traps the solvent between itself and the inside wall of the tube by surface tension. The solution of extract in solvent, which then becomes spread over the wall of the tube, can then be collected by brief centrifugation into the bottom of the tube, from whence it can be drawn into the capillary used for spotting.
The idealsolventor solventmixture should have a low volatility, should dissolve most or all of the dried extract, and should be chosen so that the compound to be assayed has a low Rf value were the solvent to be used to develop it on a thin-layerchromatographic plate. For the strongly-basic /3-blockers we have found that an equivolume mixture of butan-1-ol and acetic acid mixture fits these conditions. Although the mixture is not too volatile, it evaporates readily from a thin-layer chromatographic plate, especially if the plate is conditioned by exposure to reduced pressure before elution. The half corresponding to the standard was charred to locate the PG spot; the other half was left uncharred. The silica on the plate containing the sample was then scraped off in the area corresponding to the R1 of the PG standard. This silica was then eluted with chloroform, filtered, and spotted on our silica plate. We then carried out our procedure as usual. After charring, we observed that the sample contained a spot with a different R (0.25) from that of the PG standard (0.18).
J.S. Cridland
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We have only limited clinical information at this time to determine the clinical significance of this finding. Of the 10 patients for whom results were spurious, only two delivered within a day of the amniocentesis. One of the newborns developed mild respiratory distress, the other apnea and bradycardia, possibly secondary to a patent ductus arteriosus. Two more patients delivered healthy babies at later dates, but these patients had positive PGs by the time of delivery. The other six women were delivered at later dates with no PG followup; all delivered healthy babies. We appreciate and share your correspondents' concern for accurate results in this crucial test.
Our package insert explains that the primary purpose of our procedure is quantitation of the US ratio with simultaneous separation of the four other known phospholipids. A marker is used to indicate the relative position of the phospholipids on our TLC plates developed with our mobile phase. 
